A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease
Clinical trial NCT03118947 · COMPLETED
Trial details
- NCT number
- NCT03118947
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2019-02-25
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.